These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 35945809)

  • 1. Toxicity evaluation of main zopiclone impurities based on quantitative structure-activity relationship models and in vitro tests.
    Yin J; Wen H; Chen H
    J Appl Toxicol; 2023 Feb; 43(2):230-241. PubMed ID: 35945809
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification and characterization of new impurities in zopiclone tablets by LC-QTOF-MS.
    Han X; Cheng FJ; Di B; Xu H; Song M; Hang TJ; Lu YT
    J Pharm Biomed Anal; 2021 May; 199():114056. PubMed ID: 33831736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Analysis and evaluation of the impurity of felodipine and its tablets].
    Zhang N; Yu LJ; Li J; Tong JW; Meng J; Zhang QM; Shi YQ
    Yao Xue Xue Bao; 2012 Feb; 47(2):223-8. PubMed ID: 22512035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification and genotoxicity evaluation of potential impurities in rabeprazole sodium using
    Du Y; Wu Y; Liu Y; Meng C; Tan L; Cai T; Wang Y; Lu Y
    Drug Chem Toxicol; 2022 Sep; 45(5):2116-2122. PubMed ID: 33829945
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of the impurities in drug products containing montelukast and in silico/in vitro genotoxicological assessments of sulfoxide impurity.
    Emerce E; Cok I; Degim IT
    Toxicol Lett; 2015 Oct; 238(2):90-9. PubMed ID: 26205398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous determination of zopiclone and its degradation product and main impurity (2-amino-5-chloropyridine) by micellar liquid chromatography with time-programmed fluorescence detection: preliminary investigation for biological monitoring.
    El-Shaheny RN; Alattas A; Nasr JJ; El-Enany N; Belal F
    J Chromatogr B Analyt Technol Biomed Life Sci; 2012 Oct; 907():49-55. PubMed ID: 22999478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative determination of zopiclone and its impurity by four different spectrophotometric methods.
    Abdelrahman MM; Naguib IA; El Ghobashy MR; Ali NA
    Spectrochim Acta A Mol Biomol Spectrosc; 2015 Feb; 137():617-24. PubMed ID: 25244295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transitioning to composite bacterial mutagenicity models in ICH M7 (Q)SAR analyses.
    Landry C; Kim MT; Kruhlak NL; Cross KP; Saiakhov R; Chakravarti S; Stavitskaya L
    Regul Toxicol Pharmacol; 2019 Dec; 109():104488. PubMed ID: 31586682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Glabrol impurity exacerbates glabridin toxicity in zebrafish embryos by increasing myofibril disorganization.
    Guo Q; Wu S; Liang W; Tan J; Liu X; Yuan Y; Li X; Zhao H
    J Ethnopharmacol; 2022 Apr; 287():114963. PubMed ID: 34971733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In silico and in vitro genotoxicity evaluation of descarboxyl levofloxacin, an impurity in levofloxacin.
    Zhu Q; Li T; Wei X; Li J; Wang W
    Drug Chem Toxicol; 2014 Jul; 37(3):311-5. PubMed ID: 24224725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Forced degradation studies of medroxyprogesterone acetate injectable suspensions (150 mg/ml) with implementation of HPLC, mass spectrometry, and QSAR techniques.
    Jenkins D; Harmon CL; Jia X; Kesselring A; Hatcher D; Grayson K; Ayres J
    J Pharm Biomed Anal; 2020 Aug; 187():113352. PubMed ID: 32480200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Capillary electrophoretic enantioselective determination of zopiclone and its impurities.
    Tonon MA; Bonato PS
    Electrophoresis; 2012 Jun; 33(11):1606-12. PubMed ID: 22736363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of unknown impurities in Coenzyme Q
    Deng Y; Chen X; Wang L; Peng X; Lin M
    J Pharm Biomed Anal; 2019 Oct; 175():112771. PubMed ID: 31330281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Separation and identification of degradation impurities of esomeprazole sodium.
    Xiao C; Yuan Y; Li J; Han Y; Shi J; Zeng W; Zu X; Jin H; Jiang R; Ni S
    Biomed Chromatogr; 2023 May; 37(5):e5593. PubMed ID: 36733994
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPTLC Method for Quantitative Determination of Zopiclone and Its Impurity.
    Naguib IA; Abdelrahman MM; El Ghobashy MR; Ali NA
    J Chromatogr Sci; 2015 Sep; 53(8):1395-9. PubMed ID: 25740427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of RP UPLC-TOF/MS, stability indicating method for omeprazole and its related substances by applying two level factorial design; and identification and synthesis of non-pharmacopoeial impurities.
    Jadhav SB; Kumar CK; Bandichhor R; Bhosale PN
    J Pharm Biomed Anal; 2016 Jan; 118():370-379. PubMed ID: 26600119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using thermal forced degradation approach for impurity profiling of budesonide solution-formulated metered dose inhalation with implementation of LC-QTOFMS and HPLC-UV.
    Peng M; Song D; Ling X; Jiang W; Zhang Y; Yang Y; Le J
    J Pharm Biomed Anal; 2022 Jan; 208():114445. PubMed ID: 34763210
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification, isolation and characterization of impurities of clindamycin palmitate hydrochloride.
    Bharathi Ch; Jayaram P; Sunder Raj J; Saravana Kumar M; Bhargavi V; Handa VK; Dandala R; Naidu A
    J Pharm Biomed Anal; 2008 Dec; 48(4):1211-8. PubMed ID: 18947955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impurity Profile of Bronchodilators used in Asthma: A Critical Review.
    Prajapati KJ; Kothari CS
    Curr Drug Discov Technol; 2018; 15(4):272-304. PubMed ID: 28875855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of in silico systems and expert knowledge for structure-based assessment of potentially mutagenic impurities.
    Sutter A; Amberg A; Boyer S; Brigo A; Contrera JF; Custer LL; Dobo KL; Gervais V; Glowienke S; van Gompel J; Greene N; Muster W; Nicolette J; Reddy MV; Thybaud V; Vock E; White AT; Müller L
    Regul Toxicol Pharmacol; 2013 Oct; 67(1):39-52. PubMed ID: 23669331
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.